|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/32 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2606070 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11746252.3 |
| Date of filing the European patent application | 2011-08-22 | |
| (97) | Date of publication of the European application | 2013-06-26 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-21 |
| (46) | Date of publication of the claims translation | 2017-04-10 |
| (86) | Number | PCT/EP2011/064407 |
| Date | 2011-08-22 |
| (87) | Number | WO 2012/022814 |
| Date | 2012-02-23 |
| (30) | Number | Date | Country code |
| 375408 P | 2010-08-20 | US |
| (72) |
ELIS, Winfried, DE
ETTENBERG, Seth, US
GARNER, Andrew Paul, US
HAUBST, Nicole, DE
KUNZ, Christian Carsten Silvester, DE
REISINGER SPRAGUE, Elizabeth Anne, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnai, atpažįstantys epiderminio augimo faktoriaus receptorių 3 (HER3) |
| ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) |
| Payment date | Validity (years) | Amount | |
| 2021-07-27 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-08-22 |